%0 Journal Article
%T Use of anlotinib in intra-abdominal desmoplastic small round cell tumors: a case report and literature review
%A Ge Feng
%A Hui-Min Chen
%J Archive of "OncoTargets and therapy".
%D 2019
%R 10.2147/OTT.S190333
%X Intra-abdominal desmoplastic small round cell tumor (IADSRCT) is a highly invasive malignant tumor that is rare in clinical practice. Anlotinib is a multitarget receptor tyrosine kinase inhibitor which inhibits vascular endothelial growth factor receptor (VEGFR) 1¨C3, fibroblast growth factor receptor (FGFR) 1¨C4, platelet-derived growth factor receptors (PDGFR) ¦Á/¦Â, c-Kit, and Met. In our study, we present a record of IADSRCT which was validly treated by anlotinib
%K intra-abdominal desmoplastic small round cell tumor
%K anlotinib
%K target therapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302812/